Why 83% of women who quit retinol never fully recover — and the 2017 UMD study that finally explains it.

If you saw the anatomical drawing on Facebook this week and recognized your own face in the labeled trouble zones — the morning redness, the sandpaper feel, the burning after wash, the patches under foundation — this is the article you came here for.

I am 53. I worked in hospital pharmacy for 17 years. I used tretinoin nightly for eight of those years because my dermatologist told me it was the gold standard. It cost me my eyesight before it cost me my wrinkles. What I learned about retinol-induced barrier collapse afterward — from a paper at the University of Maryland, from a private conversation with a functional MD, and from my own face in a 10x mirror — is what this page is about.

Here is the part that still makes me sit down. It cost me my eyesight before it cost me my wrinkles, and I never even got the smooth skin I started it for. Eight years on tretinoin. I bought it for the lines on my forehead. I ended up with burning eyes, crepe under them, and deeper lines than the day I opened the first tube.

Not the day I quit. The morning I knew I had to.

It was 4 a.m. My eyes burned the way they had burned for two years. The skin under them felt like crepe paper that someone had left in the rain and tried to smooth back out. I went to the bathroom to splash cold water on my face and I caught my reflection in the 10x mirror before I was ready to see it. I winced. My own face. I winced at it.

There was a tube of tretinoin on the counter. The third one that year. I picked it up, walked it to the kitchen trash, and dropped it in. Then I came back, sat on the edge of the tub in the dark, and cried for about ten minutes. Not loud. The way you cry when your daughter is asleep down the hall and you don’t want her to hear it.

A week earlier, my daughter had sent me a text from her dorm. She asked why I kept turning my camera off during our FaceTime calls. I had told her the lighting was bad. The lighting was not bad. I was hiding my face from my own kid.

What I didn’t know that morning — what no dermatologist in twelve appointments had explained to me — was that the redness wasn’t aging, and it wasn’t hormonal, and it wasn’t “just perimenopause.” It was a name nobody on the prescription pad had ever said out loud: retinol-induced barrier collapse. Eight years of forcing my skin cells to divide faster than they could mature had emptied the tank.

I found this on a skincare forum a month later. I copied it into a note on my phone because it could have been written by me.

Four facts. Four receipts. Read them slowly.

One. The FDA classifies topical retinol as an irritant. Not a drug for healthy skin. An irritant. That word lives in the actual regulatory paperwork. Your dermatologist knows this. The skincare counter at the department store does not say it out loud.

Two. Between 20 and 50 percent of women who use retinoids develop dry eye and inflammation of the eyelid margin. There is a name for it. Blepharoconjunctivitis. The number comes from City Skin Clinic’s review of retinoid side effects, and the women on the forums have been describing it for years before anyone clinical wrote it down. “My eyes glued shut from the irritation.” “Permanent dry eye, confirmed by my doctor.” It is not rare. It is just not advertised.

Three. Retinol thins the outer layer of your skin. The stratum corneum. The exact layer that is supposed to keep moisture in and irritants out. I saw a woman post this on a skincare subreddit and I had to sit with it for a minute.

Read that twice. The product that is supposed to be the gold standard for aging skin is thinning the part of your skin that protects you. That is not a side effect. That is the mechanism.

Four. The whole “gold standard” framing runs on billing codes, not biology.

Tretinoin, the prescription version of retinol, has an insurance code. Pharmacies can dispense it. Dermatologists can bill for visits to monitor it. The system is built to keep the molecule moving through the supply chain. Tallow, copper peptides, methylene blue, none of those have billing codes. Insurance doesn’t pay for them. There is no class in the derma textbook with their names on it. So they don’t get prescribed. That is not a conspiracy. That is just how the plumbing works.

So if retinol is not actually the gold standard, what is the longevity research community using instead?

Tom’s brother David is a research scientist at Duke. Mitochondrial biology. Thanksgiving 2023, I was halfway through my second glass of wine, complaining that nothing was helping my skin heal. He listened. Then he set his glass down and said:

“You ever heard of methylene blue?”

I said: the dye? Like the kind they use to find cancer?

He said: yeah, that one. He told me about a paper out of UMD. A researcher named Kan Cao. Published in Nature Scientific Reports in 2017. He said: “It’s been used in medicine for a hundred and fifty years. It does something to mitochondria that retinol doesn’t.”

I wrote “Kan Cao Nature 2017” on a Thanksgiving napkin. I still have it in a drawer.

David doesn’t know I’m writing this. He’s a private person and he wasn’t pitching me a product. He was trying to help a sister-in-law who was crying at her own reflection. But that conversation is why this jar exists.

I drove home from his place, opened the laptop, and didn’t stop reading until 2 a.m. The Cao paper first. Then everything she cited. Then forty years of mitochondrial-biogenesis literature. None of it was hidden — it just wasn’t in any skincare textbook I’d ever read.

I will name three things. None of them are new. All three are in the published literature. All three are on the shelves of women I know who used to spend $200 a month on serums and now spend a lot less.

Methylene Blue. First synthesized in 1876. Used in medicine for 150 years. It is on the World Health Organization’s list of essential medicines. Dr. Kan Cao, a cell biologist at the University of Maryland, published a paper in Nature Scientific Reports in 2017 showing that methylene blue affected the way skin cells signal during aging. The paper is real. The journal is Nature. Emerging research suggests it works upstream of the things retinol tries to force. It is not new. It is just not on the dermatology syllabus.

GHK-Cu. A copper peptide. Discovered by Dr. Loren Pickart in 1973. He has been publishing on it for half a century. It is in PubMed. It is naturally present in human blood. It signals cells to repair themselves at a low, daily-use cosmetic dose. Nobody on the derma syllabus learned about it because there is no billing code for it.

Tallow. Rendered beef fat. The thing women put on their faces for a thousand years before the cosmetics industry replaced it with petroleum derivatives in the early 1900s. The fatty acid profile of tallow is closer to human sebum than almost anything you can buy. Your skin recognizes it. Petroleum, it doesn’t.

That is what David told me to look up. That is what I found.

When I went looking for a single product that combined those three, I could not find one. So I built one. The brand is called REVYVE. The product is a balm. The mechanism is something I call Triple Signal.

Recharge. Methylene blue signals the mitochondria inside your skin cells. The mitochondria are the part of the cell that makes energy. After 40, they make less of it. Methylene blue helps them make more.

Signal. GHK-Cu peptide signals the cells in your dermis to start repairing themselves. It is not forcing anything. It is asking. The cells respond because GHK-Cu is a molecule they already recognize from your own blood.

Feed. Tallow, honey, and jojoba feed the barrier with lipids your skin recognizes. Bioidentical, not synthetic. Your skin does not have to translate them.

I am going to put the receipts on the table now. If you came this far, you deserve them.

The Cao paper. Dr. Kan Cao runs a cell biology lab at the University of Maryland. She was not studying skincare. She was studying a rare disease that ages children at the cellular level. In 2017 her lab published a paper in Nature Scientific Reports showing that methylene blue affected the way human skin cells behaved as they aged. The cells held onto their function longer. They produced more of the things skin needs to stay intact. The paper is not a press release. It is in the journal. You can pull it up on your phone right now. The DOI is on the header. Nature is not a wellness blog.

Anti-Aging Potentials of Methylene Blue for Human Skin Longevity. Xiong, O’Donovan, Sun, Choi, Ren and Cao. Scientific Reports, May 30, 2017.

The Pickart citation. Dr. Loren Pickart isolated the GHK peptide from human blood plasma in 1973. He has been publishing on it ever since. His work is on PubMed. The molecule is not a copy of something your body uses. It is something your body already uses. When your skin sees GHK-Cu in a cream, it does not have to learn what it is. It recognizes it.

PubMed · Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells. Nat New Biol. 1973 May 30;243(127):85-7. PMID: 4541380.

The 150-year timeline for methylene blue. Synthesized in 1876 in a German dye lab. Used to stain bacteria under the microscope. In 1891 it became the first synthetic drug ever used in medicine, when doctors used it to treat malaria. It is still carried on the World Health Organization’s list of essential medicines today. That is not a wellness trend. That is one of the oldest synthetic molecules in clinical use.

People ask me this every week. If methylene blue and copper peptides are this well documented, why hasn’t my dermatologist mentioned them? It is a fair question. The answer is not exciting. It is plumbing.

Tretinoin has a billing code. Insurance pays for it. Pharmacies dispense it. A dermatologist can write the script, schedule the follow-up, and bill for both. The whole loop is built. Tallow has no billing code. Copper peptides have no billing code. Methylene blue has a billing code only for hospital use, not for skin. If a molecule cannot move through the insurance system, it does not move through the prescription system. Nobody is hiding it. The plumbing just does not run that way.

The dermatology syllabus is the second piece. The textbook teaches retinoids because retinoids are what dermatology built itself around in the 1970s and 1980s. Signaling molecules came later. The curriculum did not get rewritten. So the next generation of dermatologists graduates knowing how to titrate tretinoin and not really knowing what GHK-Cu is. That is not their fault. They were taught what they were taught.

The third piece is the money. The luxury skincare category lives on the gap between cost and price. A serum that costs $4 to formulate sells for $400. That margin only works if the active ingredient is hard to source, hard to copy, and easy to brand. Tallow is none of those things. Methylene blue is none of those things. A mechanism-led product cannibalizes the margin model. Big Beauty has no reason to push it.

It’s not a conspiracy. It’s an incentive structure.

So let me say the quiet part. I did not start tretinoin for fun. I started it for one reason, the same reason you did. My wrinkles. And here is what no one on the prescription pad ever said out loud: the whole time I was chasing smooth on the surface, the retinol was thinning the skin underneath my own hand. I got the burning. I got the crepe. I got the eye doctor in the parking lot. What I never got was the smooth, firm skin I started the whole thing for.

I’m 53. I quit tretinoin 18 months ago. I’m the woman who read the papers, trusted my body when it said no, and walked away from the cult of forced renewal.

Three weeks ago I was at the Sephora in the mall buying a brow pencil. The girl at the counter tried to sell me a new retinol-bakuchiol serum. I held up my hand and said, kindly, “I’m done with retinol. Forever.” I walked past every retinol bottle on every shelf. Out the door. Into the afternoon. And I felt free. The way I used to feel before I was told — for eight years — that my skin was the problem that needed correcting every night.

My morning is quiet now. I wash with water. I press the balm in with my fingertips. The redness is gone. The sandpaper is gone. The wincing in the mirror is gone. The woman retinol tried to perfect away is still here.

If you saw the anatomical drawing this week and you recognized your face in it — the trouble zones, the labels, the dots — I built the balm I wish someone had handed me eight years ago. There’s a 60-day guarantee. You do not have to return the jar. If it does not work, I send the money back and we move on.

Your skin was never the problem. It was the product. And the product can change.